Korbel Gregory Alan Insider Trades

Insider Trading History

Track insider trading activity for Korbel Gregory Alan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Operating Officer
Holding Value $35.5k 45,762 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 60,000 shares
$21.80
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Operating Officer
Holding Value $16.6k 21,462 shares
Last Trade
Jun 03, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$140k 8,390 shares
$16.63
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $56.3k 72,600 shares
Last Trade
Mar 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.23M 88,600 shares
$36.40
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $23.1k 29,852 shares
Last Trade
Mar 10, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$72.4k 1,989 shares
$36.40
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $12.3k 15,841 shares
Last Trade
Feb 25, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$46.1k 1,326 shares
$34.80
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $1.81k 2,335 shares
Last Trade
Dec 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.1M 27,500 shares
$76.40
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $34.6k 44,667 shares
Last Trade
Dec 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.1M 27,500 shares
$76.40
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $13.3k 17,167 shares
Last Trade
Dec 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.1M 27,500 shares
$76.40
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $34.6k 44,667 shares
Last Trade
Nov 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.77M 27,500 shares
$100.80
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $23.1k 29,835 shares
Last Trade
Nov 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.77M 27,500 shares
$100.80
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $13.3k 17,167 shares
Last Trade
Nov 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.77M 27,500 shares
$100.80
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $34.6k 44,667 shares
Last Trade
Oct 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.74M 27,500 shares
$99.50
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $19.6k 25,245 shares
Last Trade
Oct 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.74M 27,500 shares
$99.50
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $13.3k 17,167 shares
Last Trade
Oct 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.74M 27,500 shares
$99.50
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $40.9k 52,745 shares
Last Trade
Sep 20, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.67M 27,500 shares
$97.00
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $34.6k 44,667 shares
Last Trade
Sep 20, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.67M 27,500 shares
$97.00
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Svp, Chief Business Officer
Holding Value $13.3k 17,167 shares
Last Trade
Sep 20, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.2M 32,960 shares
$97.00
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Chief Business Officer
Holding Value $17.5k 22,627 shares
Last Trade
Sep 10, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$158k 1,724 shares
$91.80
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
Chief Business Officer
Holding Value $18.9k 24,351 shares
Last Trade
Aug 25, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$91.5k 1,149 shares
$79.60
$0.78
Aprea Therapeutics
Aprea Therapeutics APRE
VP Of Business Dev't
Holding Value $19.8k 25,500 shares
Last Trade
Mar 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.72M 15,000 shares
$114.60
$0.78

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up